Date: Thursday 12 Jan 2012
Reckitt Benckiser: J.P. Morgan Cazenove downgrades to neutral from overweight.
| Total Voting Rights | 02-Feb-2012 | 07:00 | RNS |
| Holding(s) in Company | 05-Jan-2012 | 10:49 | RNS |
| Blocklisting Six Monthly Return | 29-Dec-2011 | 07:00 | RNS |
| CANCER THERAPY COLLABORATION WITH ASTRAZENECA | 21-Dec-2011 | 07:00 | RNS |
| Chi-Med Loan Facility | 12-Dec-2011 | 07:00 | RNS |
| Chinese medicine firm employs Cambridge Universi... | 23-Dec-2009 | Guardian |
| Joint venture offers food for growth | 09-Oct-2009 | The Scotsman |
| Chi-Med unveils maiden profit | 31-Jul-2009 | The Scotsman |
| Chi-Med happy with drug tests | 14-Jul-2009 | The Scotsman |
| 'Watershed' year depends on US drugs trial says ... | 17-Mar-2009 | The Scotsman |
| Questor: Hutchison China Meditech | 03-Jul-2007 | Telegraph |
| The Week Ahead: Wolseley investors seek calm ami... | 19-Mar-2007 | The Independent |
| The Investment Column: Hutchison China MediTech | 21-Nov-2006 | The Independent |
| Shares That Sound Good | 02-Jun-2006 | Motley Fool UK |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 415.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 535.00 |
| 52 Week Low | 263.00 |
| Volume | 103,496 |
| Shares Issued | 51.74m |
| Market Cap | £214.73m |
| Beta | 0.28 |
| RiskGrade | 247 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 15:20 | 500 @ 416.47p |
| 12:17 | 1,900 @ 407.00p |
| 11:31 | 50,446 @ 415.00p |
| 11:31 | 50,000 @ 415.00p |
| 09:38 | 650 @ 405.00p |
You are here: research